Skip to main content
Simone Krebs, MD, Nuclear Medicine, Houston, TX

Simone Krebs MD


Assistant Attending

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Dr. Krebs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Nuclear Medicine, 2016 - 2018
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine, 2014 - 2016
  • Albert Ludwigs University Faculty of Medicine
    Albert Ludwigs University Faculty of MedicineClass of 2006

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2024 - 2026
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2017 - 2025
  • Nuclear Medicine
    American Board of Nuclear Medicine Nuclear Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Biodistribution and Radiation Dose Estimates for 68Ga-DOTA-JR11 in Patients with Metastatic Neuroendocrine Tumors  
    Simone Krebs, Lisa Bodei, Diane Reidy, Bradley J Beattie, Wolfgang A Weber, European Journal of Nuclear Medicine and Molecular Imaging

Press Mentions

  • Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
    Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid TumorsApril 23rd, 2025
  • Novel Radiolabeled Antibody Developed for Diagnosis and Treatment of Solid Tumors
    Novel Radiolabeled Antibody Developed for Diagnosis and Treatment of Solid TumorsApril 19th, 2025
  • New Radiolabeled Antibody Emerges for Enhanced Diagnosis and Treatment of Solid Tumors
    New Radiolabeled Antibody Emerges for Enhanced Diagnosis and Treatment of Solid TumorsApril 18th, 2025
  • Join now to see all

Grant Support

  • Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten captureUNIVERSITY OF TX MD ANDERSON CAN CTR2021–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: